Amedeo Smart

Free Medical Literature Service

 

Amedeo

Peptic Ulcer
  Free Subscription

Articles published in
Gastroenterology
    February 2026
  1. SAMNANI S, Forbes N
    Risk of Stomach Cancer with Long-term Use of Proton Pump Inhibitors.
    Gastroenterology. 2026 Feb 25:S0016-5085(26)00191.
    >> Share

  2. SAFAR H, Mahamud O, Talwar S, Sung J, et al
    Helicobacter Pylori Eradication in Healthy Adults Not Strongly Associated With Improved Mortality: A Fragility Index Analysis.
    Gastroenterology. 2026 Feb 5:S0016-5085(26)00089.
    >> Share

    January 2026
  3. GAO W, Li J, Yang G, Du S, et al
    Vonoprazan-tetracycline dual regimen as rescue therapy for Helicobacter pylori infection: randomized controlled trial.
    Gastroenterology. 2026 Jan 29:S0016-5085(26)00031.
    >> Share

    November 2025
  4. KAMEOKA E, Saito H, Hikichi T, Nakamura J, et al
    Clarifying Gastric Cancer Risk After Helicobacter pylori Eradication.
    Gastroenterology. 2025 Nov 18:S0016-5085(25)06040.
    >> Share

  5. JI J, Shi X, Luo N, Liang L, et al
    Comments on "Risk of Gastric Adenocarcinoma After Eradication of Helicobacter pylori".
    Gastroenterology. 2025 Nov 18:S0016-5085(25)06037.
    >> Share

  6. CHEN J, Yan L
    Methodological Considerations in the Meta-Analysis on Helicobacter pylori Eradication for Gastric Cancer Prevention.
    Gastroenterology. 2025 Nov 18:S0016-5085(25)06029.
    >> Share

  7. XIE Q, Zhang F, Wang J
    Comments on "Eradication Therapy to Prevent Gastric Cancer in Helicobacter pylori-Positive Individuals".
    Gastroenterology. 2025 Nov 17:S0016-5085(25)06028.
    >> Share

  8. SHI Z, Jia J, Shan L, Yang C, et al
    Multi-Mechanistic Persistence of Gastric Cancer Risk Post-Helicobacter pylori and Surveillance Strategies.
    Gastroenterology. 2025 Nov 15:S0016-5085(25)06039.
    >> Share

  9. XING H, Su Y, Zhang LY
    Correspondence on "Risk of Gastric Adenocarcinoma After Eradication of Helicobacter pylori".
    Gastroenterology. 2025 Nov 15:S0016-5085(25)06038.
    >> Share

  10. MULDER DT, O'Mahony JF, Kapteijn N, Bric TK, et al
    The Disease Burden of Helicobacter pylori Beyond Gastric Cancer: Quantifying the Forgotten Potential Benefits of Mass Eradication.
    Gastroenterology. 2025 Nov 14:S0016-5085(25)05900.
    >> Share

    October 2025
  11. OBEIDAT M, Floria DE, Teutsch B, Abonyi-Toth Z, et al
    Hemodynamic Status as a Determinant Factor of Optimal Endoscopy Timing in Upper Gastrointestinal Bleeding: Results From an International Survey of 533 Clinicians.
    Gastroenterology. 2025 Oct 20:S0016-5085(25)05899.
    >> Share

  12. WONG MW, Hsiao SH, Wang JH, Gyawali CP, et al
    Reduced Esophageal Hypervigilance and Symptom-Specific Anxiety in Barrett's Esophagus: A Deficient Alarm Signal for Gastroesophageal Reflux Disease-Associated Mucosal Injury.
    Gastroenterology. 2025 Oct 20:S0016-5085(25)05898.
    >> Share

  13. YANG C, Shi Z, Zhang C
    Cautious Implementation of Helicobacter pylori Eradication in the Elderly.
    Gastroenterology. 2025 Oct 6:S0016-5085(25)06104.
    >> Share

  14. TANG X, Zhao J, Hu J, Zhang L, et al
    Comments on "Preventive effect of Helicobacter pylori treatment on gastric cancer incidence and mortality: A Korean population study".
    Gastroenterology. 2025 Oct 6:S0016-5085(25)06103.
    >> Share

  15. LI K, Lin A, Luo P
    Revisiting gender differences in gastric cancer prevention with Helicobacter pylori eradication therapy.
    Gastroenterology. 2025 Oct 6:S0016-5085(25)06100.
    >> Share

  16. CHEN H, Liu S, Zhi H, Zheng J, et al
    Methodological Considerations in Evaluating the Preventive Effect of Helicobacter pylori Eradication on Gastric Cancer Incidence and Mortality.
    Gastroenterology. 2025 Oct 6:S0016-5085(25)06101.
    >> Share

    September 2025
  17. PITTAYANON R, Alali AA, Barkun AN
    How should endoscopists approach patients with upper gastrointestinal bleeding and persistent hemodynamic instability?
    Gastroenterology. 2025 Sep 10:S0016-5085(25)05991.
    >> Share

    August 2025
  18. BARKUN AN, Laine L, Leontiadis GI, Gralnek IM, et al
    Canadian Association of Gastroenterology Clinical Practice Guideline for the Endoscopic Management of Nonvariceal Nonpeptic Ulcer Upper Gastrointestinal Bleeding.
    Gastroenterology. 2025 Aug 8:S0016-5085(25)00901.
    >> Share

    May 2025
  19. LIU ZC, Li WQ
    Revisiting Helicobacter pylori eradication: evolving evidence and global implications for gastric cancer prevention.
    Gastroenterology. 2025 May 14:S0016-5085(25)00715.
    >> Share

    April 2025
  20. JUNG YS, Tran MTX, Park B, Moon CM, et al
    Preventive effect of Helicobacter pylori treatment on gastric cancer incidence and mortality: A Korean population study.
    Gastroenterology. 2025 Apr 8:S0016-5085(25)00607.
    >> Share

    February 2025
  21. WIKLUND AK, Santoni G, Yan J, Radkiewicz C, et al
    Risk of gastric adenocarcinoma after eradication of Helicobacter pylori.
    Gastroenterology. 2025 Feb 7:S0016-5085(25)00356.
    >> Share

    November 2024
  22. PATEL A, Laine L, Moayyedi P, Wu J, et al
    AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review.
    Gastroenterology. 2024;167:1228-1238.
    >> Share

    October 2024
  23. TANG WZ, Liu TH, Li YB
    Assessing the Preventative Effects of Vonoprazan Relative to Intravenous Proton Pump Inhibitors Following Endoscopic Intervention in Peptic Ulcers.
    Gastroenterology. 2024 Oct 22:S0016-5085(24)05589.
    >> Share

    September 2024
  24. KETCHEM CJ
    The Impact of Population-Based Helicobacter pylori Test-To-Treat Strategies on Gastric Cancer Outcomes.
    Gastroenterology. 2024 Sep 25:S0016-5085(24)05528.
    >> Share

  25. NIU Y, Aihaiti X, Li M
    Evaluating Research Strategy and Inclusion Criteria of Long-term Proton Pump Inhibitor Use.
    Gastroenterology. 2024 Sep 20:S0016-5085(24)05481.
    >> Share

  26. CHEN H, Ren C
    Helicobacter pylori Eradication Treatment Might Help Reduce the Risk of Esophageal Adenocarcinoma.
    Gastroenterology. 2024 Sep 19:S0016-5085(24)05477.
    >> Share

  27. GUO X, Wang Y
    Enhancing Research on Helicobacter pylori Eradication and Esophageal Adenocarcinoma Risk: A Call for Broader Studies and Methodological Rigor.
    Gastroenterology. 2024 Sep 19:S0016-5085(24)05476.
    >> Share

  28. HOFT SG, Brennan M, Carrero JA, Jackson NM, et al
    UNVEILING CANCER-RELATED METAPLASTIC CELLS IN BOTH HELICOBACTER PYLORI INFECTION AND AUTOIMMUNE GASTRITIS.
    Gastroenterology. 2024 Sep 3:S0016-5085(24)05415.
    >> Share

    May 2024
  29. SATO R, Matsumoto K, Otsuka M
    A Duodenal Ulcer and Biliopancreatic Lesions: What is the Culprit?
    Gastroenterology. 2024 May 29:S0016-5085(24)05003.
    >> Share

    April 2024
  30. GEERATRAGOOL T, Kaosombatwattana U, Boonchote A, Chatthammanat S, et al
    Comparison of Vonoprazan versus Intravenous Proton Pump Inhibitor for Prevention of High-Risk Peptic Ulcers Rebleeding after Successful Endoscopic Hemostasis: A Multicenter Randomized Noninferiority Trial.
    Gastroenterology. 2024 Apr 5:S0016-5085(24)00362.
    >> Share

    March 2024
  31. KALLUMKAL G, McCallen J, Contarino M
    Recurrent Duodenal Ulceration - More Than Simple Peptic Ulcer Disease?
    Gastroenterology. 2024 Mar 24:S0016-5085(24)00354.
    >> Share

  32. KIM H, Nzabarushimana E, Huttenhower C, Chan AT, et al
    Altered microbial transcription in long-term proton pump inhibitor usage: findings from a US cohort study.
    Gastroenterology. 2024 Mar 21:S0016-5085(24)00309.
    >> Share

  33. WIKLUND AK, Santoni G, Yan J, Radkiewicz C, et al
    Risk of esophageal adenocarcinoma after Helicobacter pylori eradication treatment in a population-based multinational cohort study.
    Gastroenterology. 2024 Mar 19:S0016-5085(24)00299.
    >> Share

  34. XU J, Deng M, Tang X
    Comments on "Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022".
    Gastroenterology. 2024 Mar 15:S0016-5085(24)00294.
    >> Share

  35. LI GF, Qiao YW, Yu G
    Helicobacter pylori Therapy and Risk of Gastric Cancer After Endoscopic Resection of Dysplasia: A Sensitivity Analysis Assessing Impact of Unmeasured Confounding.
    Gastroenterology. 2024 Mar 14:S0016-5085(24)00292.
    >> Share

    February 2024
  36. UCHIYAMA T, Saito H, Nishikawa Y
    Lessons from Japan's Case for Early Helicobacter pylori Screening.
    Gastroenterology. 2024 Feb 29:S0016-5085(24)00245.
    >> Share

  37. SHIRATORI Y, Ishii N, Kalloo A
    Metachronous Gastric Cancer Outcomes Following H-pylori Therapy after Endoscopic Dysplasia Resection: Insights from a Global Real-World Study.
    Gastroenterology. 2024 Feb 18:S0016-5085(24)00176.
    >> Share

    January 2024
  38. CHEN YC, Malfertheiner P, Yu HT, Kuo CL, et al
    Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022.
    Gastroenterology. 2024 Jan 2:S0016-5085(23)05687.
    >> Share

    November 2023
  39. SUN D, Mulder DT, Li Y, Nieboer D, et al
    The Effect of Nationwide Organized Cancer Screening Programs on Gastric Cancer Mortality: a Synthetic Control Study.
    Gastroenterology. 2023 Nov 23:S0016-5085(23)05562.
    >> Share

  40. CHEN YY, Chang HM, Chen CH
    A Rare Cause of Duodenal ulcer.
    Gastroenterology. 2023 Nov 8:S0016-5085(23)05225.
    >> Share

  41. MURUAGA EJ, Jones NL
    Helicobacter pylori genetic variations: A driver of gastric cancer progression?
    Gastroenterology. 2023 Nov 8:S0016-5085(23)05226.
    >> Share

  42. FORD AC, Graham DY
    Toward quantification of H. pylori-associated gastric cancer risk: Further evidence supporting development of population-based strategies for H. pylori eradication.
    Gastroenterology. 2023 Nov 2:S0016-5085(23)05203.
    >> Share

    October 2023
  43. YOO HW, Hong SJ, Kim SH
    Helicobacter pylori Treatment and Gastric Cancer Risk after Endoscopic Resection of Dysplasia: A Nationwide Cohort Study.
    Gastroenterology. 2023 Oct 18:S0016-5085(23)05140.
    >> Share

  44. MOSS SF, Shah SC, Tan MC, El-Serag HB, et al
    Evolving Concepts in Helicobacter pylori management.
    Gastroenterology. 2023 Oct 6:S0016-5085(23)05083.
    >> Share

    September 2023
  45. UCHIYAMA T, Saito H, Nishikawa Y
    Helicobacter pylori Eradication in the United States: A Deeper Exploration of Demographics, Strain Variations, and Clinical Implications.
    Gastroenterology. 2023 Sep 5:S0016-5085(23)04974.
    >> Share

    June 2023
  46. MEHTA R, Kochar B, Zhou Z, Broder JC, et al
    ASSOCIATION OF PROTON PUMP INHIBITOR USE WITH INCIDENT DEMENTIA AND COGNITIVE DECLINE IN OLDER ADULTS: A PROSPECTIVE COHORT STUDY.
    Gastroenterology. 2023 Jun 12:S0016-5085(23)00873.
    >> Share

  47. SALEH CMG, Familiari P, Bastiaansen BAJ, Fockens P, et al
    The Efficacy of Peroral Endoscopic Myotomy vs Pneumatic Dilation as Treatment for Patients With Achalasia Suffering From Persistent or Recurrent Symptoms After Laparoscopic Heller Myotomy: A Randomized Clinical Trial.
    Gastroenterology. 2023;164:1108-1118.
    >> Share

    May 2023
  48. GUO H, Stach J, Belletrutti PJ
    GASTRO CURBSIDE CONSULT: A Rare Cause of Life-Threatening Upper Gastrointestinal Bleeding.
    Gastroenterology. 2023 May 26:S0016-5085(23)00746.
    >> Share

    April 2023
  49. LI D, Jiang SF, Lei NY, Shah SC, et al
    Effect of Helicobacter pylori Eradication Therapy on the Incidence of Noncardia Gastric Adenocarcinoma in a Large Diverse Population in the United States.
    Gastroenterology. 2023 Apr 30:S0016-5085(23)00695.
    >> Share

  50. FORBES N
    Over-the-Scope Clips in the Initial Endoscopic Treatment of Nonvariceal Upper Gastrointestinal Bleeding: Ready for Prime Time?
    Gastroenterology. 2023 Apr 14:S0016-5085(23)00615.
    >> Share

  51. SONG K, Zhou Q, Wu D
    A rare cause of refractory gastric ulcer.
    Gastroenterology. 2023 Apr 11:S0016-5085(23)00588.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016